We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$70B
AUM Growth
+$5.31B
Cap. Flow
-$1.28B
Cap. Flow %
-1.83%
Top 10 Hldgs %
18.76%
Holding
4,050
New
386
Increased
1,661
Reduced
1,461
Closed
319

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.08B
2
AAPL icon
Apple
AAPL
+$70.3M
3
BLK icon
Blackrock
BLK
+$65.2M
4
LRCX icon
Lam Research
LRCX
+$62.8M
5
SN icon
SharkNinja
SN
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 13.57%
2 Financials 9.89%
3 Consumer Discretionary 6.39%
4 Healthcare 6.15%
5 Industrials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWA icon
3451
CALL
iShares MSCI Australia ETF
EWA
$1.34B
$32K ﹤0.01%
13,000
+8,000
+160% +$202K
FXI icon
3452
CALL
iShares China Large-Cap ETF
FXI
$4.14B
$32K ﹤0.01%
+11,000
New +$291K
ENPH icon
3453
PUT
Enphase Energy
ENPH
$4.84B
$31.8K ﹤0.01%
3,600
+600
+20% +$67K
CRON
3454
CALL
Cronos Group
CRON
$1.05B
$31.4K ﹤0.01%
77,000
+41,000
+114% +$93.8K
DDD icon
3455
3D Systems Corp
DDD
$420M
$31K ﹤0.01%
+11,244
New +$32.3K
ALLY icon
3456
PUT
Ally Financial
ALLY
$13.1B
$30.4K ﹤0.01%
+45,000
New +$1.8M
TLRY icon
3457
CALL
Tilray
TLRY
$479M
$30.4K ﹤0.01%
7,400
+200
+3% +$3.6K
CGC
3458
Canopy Growth
CGC
$375M
$30K ﹤0.01%
8,033
+2,522
+46% +$15.3K
LSTA icon
3459
Lisata Therapeutics
LSTA
$15.2M
$30K ﹤0.01%
10,042
-2
-0% -$6
NB
3460
NioCorp Developments
NB
$603M
$30K ﹤0.01%
14,170
ATCH icon
3461
AtlasClear
ATCH
$26.5M
$30K ﹤0.01%
2,482
+1,241
+100% +$29K
NVDA icon
3462
CALL
NVIDIA
NVDA
$5.01T
$29.7K ﹤0.01%
2,300
-108,400
-98% -$12.8M
MYSE
3463
Myseum.AI Inc
MYSE
$12.8M
$29K ﹤0.01%
22,383
-3,000
-12% -$4.06K
MCHX icon
3464
Marchex
MCHX
$79.7M
$29K ﹤0.01%
15,708
HYLN icon
3465
Hyliion Holdings
HYLN
$663M
$28K ﹤0.01%
11,460
-22,894
-67% -$46.1K
CRUS icon
3466
CALL
Cirrus Logic
CRUS
$6.74B
$27.3K ﹤0.01%
+12,000
New +$1.59M
ABCL icon
3467
AbCellera Biologics
ABCL
$1.62B
$27K ﹤0.01%
10,486
-3,500
-25% -$9.7K
OGI
3468
Organigram Holdings
OGI
$132M
$27K ﹤0.01%
15,020
-8,000
-35% -$13.9K
TOI icon
3469
The Oncology Institute
TOI
$498M
$27K ﹤0.01%
81,362
+53,382
+191% +$22.1K
CTV
3470
DELISTED
Innovid Corp.
CTV
$27K ﹤0.01%
15,000
PACB icon
3471
Pacific Biosciences
PACB
$422M
$26K ﹤0.01%
16,598
-8,318
-33% -$13.7K
VNDA icon
3472
Vanda Pharmaceuticals
VNDA
$312M
$26K ﹤0.01%
5,481
-999
-15% -$5.36K
CSL icon
3473
PUT
Carlisle Companies
CSL
$13.6B
$26K ﹤0.01%
4,000
-1,000
-20% -$414K
FL
3474
CALL
DELISTED
Foot Locker
FL
$25.9K ﹤0.01%
+45,000
New +$1.24M
AXP icon
3475
PUT
American Express
AXP
$223B
$25.8K ﹤0.01%
11,000
-5,000
-31% -$1.25M

Similar funds

HighTower Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, HighTower Advisors held 4,050 positions worth $70B, up 8.2% from $64.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

HighTower Advisors's Q3 2024 filing shows 386 new, 1,661 increased, 1,461 reduced and 319 closed positions. Its largest new stake was Invesco KBW Property & Casualty Insurance ETF: 193,791 shares worth $22.4M. The largest sale was Microsoft, an estimated $2.08B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

  • HighTower Advisors's largest Q3 2024 buy was Invesco KBW Property & Casualty Insurance ETF: 193,791 shares worth $22.4M.
  • HighTower Advisors added most to Morgan Stanley in Q3 2024, an estimated $57.4M increase.
  • HighTower Advisors's biggest Q3 2024 reduction was Apple, cutting an estimated $70.3M.
  • HighTower Advisors fully exited Microsoft in Q3 2024, selling an estimated $2.08B.
  • HighTower Advisors's ten largest holdings make up 19% of its $70B portfolio in Q3 2024.
  • HighTower Advisors opened 386 new positions and closed 319 in Q3 2024.
  • HighTower Advisors's portfolio value rose 8.2% quarter-over-quarter to $70B.

Based on HighTower Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.